Project scope

To understand price potential for a sickle cell disease product in GCC markets

Challenge

Our client has a sickle disease portfolio and wanted to understand how to optimally launch in GCC markets through understanding price potential and feasibility of innovative contracting in order to boost patient access

Solution

• In depth secondary research was conducted focusing on understanding the prevalence of SCD, patient journey and competitor products
• Conducted primary research consisting of qualitative and quantitative discussions to understand the nuances within the SCD landscape across key geographies
• Tested the price and access potential of the novel therapeutic agent

Results

• Successfully enabled our client to develop localised contracts and access strategy in each key market
• Recommended optimal launch sequence to manage international price referencing risks